Article

Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma

2014-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eb1f2379-f1e1-57c5-9ab6-2919b339044a
DOI: 10.1186/2051-1426-2-s3-p2
PMCID: PMC4288583

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanomaDOI 10.1186/2051-1426-2-s3-p2Read

Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma.Semantic proximity Read

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapySemantic proximity Read

<i>Setdb1</i> -loss induces type-I interferons and immune clearance of melanomaSemantic proximity Read

PRMT1 acts as a suppressor of MHC-I and anti-tumor immunitySemantic proximity Read

The A to I editing landscape in melanoma and its relation to clinical outcome.Semantic proximity Read

LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsivenessSemantic proximity Read

RNA Editing Signatures Predict Response to Immunotherapies in Melanoma PatientsSemantic proximity Read

Locus-Specific DNA Methylation Editing in Mammalian Cells using a CRISPR-Based SystemSemantic proximity Read

Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer ImmunotherapySemantic proximity Read

The indoleamine 2,3 dioxygenase pathway drives intratumoral B cell maintenanceSemantic proximity Read

Escape from nonsense-mediated decay associates with anti-tumor immunogenicitySemantic proximity Read

Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunitySemantic proximity Read